• Something wrong with this record ?

Genomics Driving Diagnosis and Treatment of Inborn Errors of Immunity With Cancer Predisposition

S. Barmettler, SO. Sharapova, T. Milota, PA. Greif, T. Magg, F. Hauck

. 2022 ; 10 (7) : 1725-1736.e2. [pub] 20220329

Language English Country United States

Document type Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural

Persistent link   https://www.medvik.cz/link/bmc22025324

Grant support
K23 AI163350 NIAID NIH HHS - United States

Inborn errors of immunity (IEI) are genetically and clinically heterogeneous disorders that, in addition to infection susceptibility and immune dysregulation, can have an enhanced cancer predisposition. The increasing availability of upfront next-generation sequencing diagnostics in immunology and oncology have uncovered substantial overlap of germline and somatic genetic conditions that can result in immunodeficiency and cancer. However, broad application of unbiased genetics in these neighboring disciplines still needs to be deployed, and joined therapeutic strategies guided by germline and somatic genetic risk factors are lacking. We illustrate the current difficulties encountered in clinical practice, summarize the historical development of pathophysiological concepts of cancer predisposition, and review select genetic, molecular, and cellular mechanisms of well-defined and illustrative disease entities such as DNA repair defects, combined immunodeficiencies with Epstein-Barr virus susceptibility, autoimmune lymphoproliferative syndromes, regulatory T-cell disorders, and defects in cell intrinsic immunity. We review genetic variants that, when present in the germline, cause IEI with cancer predisposition but, when arising as somatic variants, behave as oncogenes and cause specific cancer entities. We finally give examples of small molecular compounds that are developed and studied to target genetically defined cancers but might also proof useful to treat IEI.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025324
003      
CZ-PrNML
005      
20221031100813.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jaip.2022.03.012 $2 doi
035    __
$a (PubMed)35364342
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Barmettler, Sara $u Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy, & Immunology, Massachusetts General Hospital, Boston, Mass
245    10
$a Genomics Driving Diagnosis and Treatment of Inborn Errors of Immunity With Cancer Predisposition / $c S. Barmettler, SO. Sharapova, T. Milota, PA. Greif, T. Magg, F. Hauck
520    9_
$a Inborn errors of immunity (IEI) are genetically and clinically heterogeneous disorders that, in addition to infection susceptibility and immune dysregulation, can have an enhanced cancer predisposition. The increasing availability of upfront next-generation sequencing diagnostics in immunology and oncology have uncovered substantial overlap of germline and somatic genetic conditions that can result in immunodeficiency and cancer. However, broad application of unbiased genetics in these neighboring disciplines still needs to be deployed, and joined therapeutic strategies guided by germline and somatic genetic risk factors are lacking. We illustrate the current difficulties encountered in clinical practice, summarize the historical development of pathophysiological concepts of cancer predisposition, and review select genetic, molecular, and cellular mechanisms of well-defined and illustrative disease entities such as DNA repair defects, combined immunodeficiencies with Epstein-Barr virus susceptibility, autoimmune lymphoproliferative syndromes, regulatory T-cell disorders, and defects in cell intrinsic immunity. We review genetic variants that, when present in the germline, cause IEI with cancer predisposition but, when arising as somatic variants, behave as oncogenes and cause specific cancer entities. We finally give examples of small molecular compounds that are developed and studied to target genetically defined cancers but might also proof useful to treat IEI.
650    12
$a infekce virem Epsteina-Barrové $7 D020031
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genomika $7 D023281
650    _2
$a virus Epsteinův-Barrové $7 D004854
650    _2
$a lidé $7 D006801
650    12
$a nádory $x diagnóza $x genetika $x terapie $7 D009369
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Sharapova, Svetlana O $u Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
700    1_
$a Milota, Tomas $u Department of Immunology, Second Faculty of Medicine, Charles University Hospital and Motol University Hospital, Prague, Czechia
700    1_
$a Greif, Philipp A $u Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, 81377 Munich, Germany; German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany
700    1_
$a Magg, Thomas $u Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
700    1_
$a Hauck, Fabian $u Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. Electronic address: fabian.hauck@med.uni-muenchen.de
773    0_
$w MED00201300 $t The journal of allergy and clinical immunology. In practice $x 2213-2201 $g Roč. 10, č. 7 (2022), s. 1725-1736.e2
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35364342 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100811 $b ABA008
999    __
$a ok $b bmc $g 1854837 $s 1176614
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 7 $d 1725-1736.e2 $e 20220329 $i 2213-2201 $m The journal of allergy and clinical immunology. In practice $n J Allergy Clin Immunol Pract $x MED00201300
GRA    __
$a K23 AI163350 $p NIAID NIH HHS $2 United States
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options